Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.
Description
Spend more quality time engaging with your patients while minimizing your interactions with electronic health records, as OncoEMR® prioritizes workflow efficiency and rapid processing. The platform is tailored for oncology practices, featuring specialized workflows and tools like Document Search that streamline tasks, cutting down work duration from minutes to mere seconds. With the introduction of MIPS, OncoEMR® provides essential resources to navigate the program successfully, assisting in the collection and reporting of mandatory data while offering support throughout the workflows and official reporting obligations. Designed specifically for community oncology practices, OncoEMR® incorporates elements such as NCCN Chemotherapy Order Templates® and the latest AJCC disease factors, transforming it into a bespoke diagnostic and treatment resource. Prior to launching OncoEMR®, Flatiron will handle the migration of your existing EHR database, allowing for a seamless transition on your first day of operation. After the migration process, you will benefit from over 150 preloaded reports, enabling you to gain valuable insights into both business operations and clinical metrics, including patient wait times, ensuring a comprehensive understanding of your practice's performance. This combination of tools and features not only enhances efficiency but also supports improved patient care and outcomes in your oncology practice.
API Access
Has API
API Access
Has API
Integrations
No details available.
Integrations
No details available.
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Omda
Founded
1999
Country
Norway
Website
omda.com/solutions/medication-management/omda-cytodose/
Vendor Details
Company Name
Flatiron Health
Founded
2012
Country
United States
Website
flatiron.com
Product Features
Product Features
Electronic Medical Records (EMR)
Appointment Management
Charting
Compliance Tracking
E-Prescribing
E/M Coding
HIPAA Compliant
Handwriting Recognition
Integrated Telehealth
MIPS Certified
Meaningful Use Certified
ONC-ATCB Certified
Patient Portal
Self Service Portal
Voice Recognition